StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30105% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Yarrow Bioscience total assets

Total assets on the balance sheet at the end of each period.

Yarrow Bioscience's total assets was $23.60M at Jun 30, 2026. For fiscal 2025 it was $30.16M, down 54.9% from the year before. The highest annual figure on record is $139.93M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.16M-54.9%
FY2024Dec 31, 2024$66.91M-31.5%
FY2023Dec 31, 2023$97.69M+139.7%
FY2022Dec 31, 2022$40.76M-39.2%
FY2021Dec 31, 2021$67.05M-28.5%
FY2020Dec 31, 2020$93.74M+15.5%
FY2019Dec 31, 2019$81.16M-42.0%
FY2018Dec 31, 2018$139.93M+109.3%
FY2017Dec 31, 2017$66.87M+59.0%
FY2016Dec 31, 2016$42.05M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.60M-58.2%
Q1 FY2026Mar 31, 2026$25.87M-61.3%
Q4 FY2025Dec 31, 2025$30.16M-60.4%
Q2 FY2025Jun 30, 2025$44.72M-48.4%
Q1 FY2025Mar 31, 2025$56.42M-38.5%
Q4 FY2024Dec 31, 2024$66.91M-31.5%
Q3 FY2024Sep 30, 2024$76.20M+295.5%
Q2 FY2024Jun 30, 2024$86.65M+247.2%
Q1 FY2024Mar 31, 2024$91.68M+160.0%
Q4 FY2023Dec 31, 2023$97.69M+139.7%
Q3 FY2023Sep 30, 2023$19.27M-58.9%
Q2 FY2023Jun 30, 2023$24.96M-54.8%
Q1 FY2023Mar 31, 2023$35.26M-45.2%
Q4 FY2022Dec 31, 2022$40.76M-39.2%
Q3 FY2022Sep 30, 2022$46.91M-42.3%
Q2 FY2022Jun 30, 2022$55.19M-58.8%
Q1 FY2022Mar 31, 2022$64.32M-56.9%
Q4 FY2021Dec 31, 2021$67.05M-28.5%
Q3 FY2021Sep 30, 2021$81.32M-24.5%
Q2 FY2021Jun 30, 2021$133.98M+2.4%
Q1 FY2021Mar 31, 2021$149.17M-7.1%
Q4 FY2020Dec 31, 2020$93.74M+15.5%
Q3 FY2020Sep 30, 2020$107.68M+11.5%
Q2 FY2020Jun 30, 2020$130.84M+14.4%
Q1 FY2020Mar 31, 2020$160.53M+27.1%
Q4 FY2019Dec 31, 2019$81.16M-42.0%
Q3 FY2019Sep 30, 2019$96.58M-37.7%
Q2 FY2019Jun 30, 2019$114.38M-31.5%
Q1 FY2019Mar 31, 2019$126.26M-30.0%
Q4 FY2018Dec 31, 2018$139.93M+109.3%
Q3 FY2018Sep 30, 2018$154.96M+268.5%
Q2 FY2018Jun 30, 2018$166.92M–
Q1 FY2018Mar 31, 2018$180.48M–
Q4 FY2017Dec 31, 2017$66.87M–
Q4 FY2016Dec 31, 2016$42.05M–

More Yarrow Bioscience figures

See a number that looks wrong?